Cargando…

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

While it is now widely accepted that host inflammatory responses contribute to lung injury, the pathways that drive severity and distinguish coronavirus disease 2019 (COVID-19) from other viral lung diseases remain poorly characterized. We analyzed plasma samples from 471 hospitalized patients recru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thwaites, Ryan S, Sanchez Sevilla Uruchurtu, Ashley, Siggins, Matthew K, Liew, Felicity, Russell, Clark D, Moore, Shona C, Fairfield, Cameron, Carter, Edwin, Abrams, Simon, Short, Charlotte-Eve, Thaventhiran, Thilipan, Bergstrom, Emma, Gardener, Zoe, Ascough, Stephanie, Chiu, Christopher, Docherty, Annemarie B, Hunt, David, Crow, Yanick J, Solomon, Tom, Taylor, Graham P, Turtle, Lance, Harrison, Ewen M, Dunning, Jake, Semple, Malcolm G, Baillie, J Kenneth, Openshaw, Peter JM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128298/ https://www.ncbi.nlm.nih.gov/pubmed/33692097 http://dx.doi.org/10.1126/sciimmunol.abg9873

Ejemplares similares

Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission
por: Relph, Katharine A, et al.
Publicado: (2022)

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
por: Drake, Thomas M, et al.
Publicado: (2021)

1670O Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory and emerging Infections Consortium, WHO Coronavirus Clinical Characterisation Consortium
por: Palmieri, C., et al.
Publicado: (2020)

LBA60 Prospective data of >20,000 hospitalised patients with cancer and COVID-19 derived from the International Severe Acute Respiratory and emerging Infections Consortium WHO Coronavirus Clinical Characterisation Consortium: CCP-CANCER UK
por: Palmieri, C., et al.
Publicado: (2021)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
por: Siggins, Matthew K., et al.
Publicado: (2021)

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses: (Trends in Microbiology, 29, 648–662, 2021)
por: Siggins, Matthew K., et al.
Publicado: (2021)

Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave
por: Read, Jonathan M, et al.
Publicado: (2021)

Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration
por: Palmieri, Carlo, et al.
Publicado: (2020)

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
por: Russell, Clark D, et al.
Publicado: (2021)

Kisspeptin and Testicular Function—Is It Necessary?
por: Sharma, Aditi, et al.
Publicado: (2020)

Fatal epidural abscess from diabetic foot disease
por: Sharma, Aditi, et al.
Publicado: (2021)

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
por: Närhi, Fiina, et al.
Publicado: (2022)

Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study
por: Geretti, Anna Maria, et al.
Publicado: (2020)

260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients
por: Swets, Maaike C, et al.
Publicado: (2022)

Seasonal and pandemic influenza: 100 years of progress, still much to learn
por: Dunning, Jake, et al.
Publicado: (2020)

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
por: Bloom, Chloe I, et al.
Publicado: (2021)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Long Covid: clues about causes
por: Liew, Felicity, et al.
Publicado: (2023)

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
por: Liew, Felicity, et al.
Publicado: (2022)

COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol
por: Marciniak, Stefan J., et al.
Publicado: (2021)

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
por: Swann, Olivia V, et al.
Publicado: (2020)

Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
por: Sullivan, Michael K, et al.
Publicado: (2021)

Clinical non-penetrance associated with biallelic mutations in the RNase H2 complex
por: Crow, Yanick J
Publicado: (2023)

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
por: Shaw, Rebecca J., et al.
Publicado: (2021)

Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study
por: Hurst, Emma A, et al.
Publicado: (2021)

Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
por: Turtle, Lance, et al.
Publicado: (2023)

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
por: Swets, Maaike C, et al.
Publicado: (2022)

Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves
por: Swann, Olivia V., et al.
Publicado: (2022)

Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study
por: Millar, Jonathan E., et al.
Publicado: (2022)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
por: Thwaites, Ryan S., et al.
Publicado: (2019)

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
por: Knight, Stephen R, et al.
Publicado: (2022)

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
por: Drake, Thomas M, et al.
Publicado: (2021)

Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease
por: Lepelley, Alice, et al.
Publicado: (2021)

(1)H NMR Signals from Urine Excreted Protein Are a Source of Bias in Probabilistic Quotient Normalization
por: Correia, Gonçalo D. S., et al.
Publicado: (2022)

Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses
por: Harris, Benjamin H L, et al.
Publicado: (2020)

GM animals - another GM crops?
por: Bruce, Ann
Publicado: (2007)

Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity
por: Swets, Maaike C., et al.
Publicado: (2023)

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
por: Docherty, Annemarie B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ia8i97utdsclfa15mhnk3q1nrv